FDA NDC Directory · JSON-LD · Markdown

AVLAYAH

NDC 84976-001 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametividenofusp alfa-eknm
Labeler / ManufacturerDenali Therapeutics Inc.
Marketing categoryBiologic License Application · App BLA761485
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTIVIDENOFUSP ALFA (150 mg/5mL)
Marketing started20260406
Package count1

External sources

Source: openFDA. Public-domain (CC0).